drug prices

A late-term maneuver by President Donald Trump to use lower drug prices paid overseas to limit some of Medicare’s costs suffered has a legal setback that appears likely to keep the policy from taking effect before the president leaves office

The coronavirus pandemic has restricted cross-border travel. People looking for cheaper prescription drugs are still making the trip south. It’s all because of high drug prices in the United States.

Pharmaceutical giant Gilead says it plans to charge at least $2,300 for a single treatment course of Remdesivir, a drug shown to shorten recovery time for severely ill coronavirus patients.

In a major legal setback for President Donald Trump on a high-profile consumer issue, a federal appeals court has ruled that his administration lacks the legal authority to force drug companies to disclose prices in their TV ads